Endogenous Dopamine Regulates the Rhythm of Expression of the Clock Protein PER2 in the Rat Dorsal Striatum via Daily Activation of D2Dopamine Receptors
Open accessAbstract
A role for dopamine (DA) in the regulation of clock genes in the mammalian brain is suggested by evidence that manipulations of DA receptors can alter the expression of some clock genes outside the suprachiasmatic nucleus (SCN), the master circadian clock. The role of endogenous DA in the regulation of clock gene expression is unknown. Here, we demonstrate a direct relationship between extracellular DA levels and the rhythm of expression of the clock protein PERIOD2 (PER2) in the dorsal striatum of the male Wistar rat. Specifically, we show that the peak of the daily rhythm of extracellular DA in the dorsal striatum precedes the peak of PER2 by ∼6 h and that depletion of striatal DA by 6-hydroxydopamine or α-methyl-para-tyrosine or blockade of D 2 DA receptors by raclopride blunts the rhythm of striatal PER2. Furthermore, timed daily activation of D 2 DA receptors, but not D 1 DA receptors, restores and entrains the PER2 rhythm in the DA-depleted striatum. None of these manipulations had any effect on the PER2 rhythm in the SCN. Our findings are consistent with the idea that the rhythm of expression of PER2 in the dorsal striatum depends on daily dopaminergic activation of D 2 DA receptors. These observations may have implications for circadian abnormalities seen in Parkinson's disease.
AI snapshot
Written from the paper’s full text.
TL;DR
Endogenous dopamine in the rat dorsal striatum regulates the daily rhythm of PER2, primarily via daily activation of D2 dopamine receptors. Depleting or blocking dopamine blunts striatal PER2, while timed D2/3 agonist treatment restores and entrains the rhythm without affecting the SCN.
Key findings
- Extracellular dopamine in the dorsal striatum peaks in the middle of the dark phase and precedes the dorsal striatum PER2 peak by ~6 h; PER2 peaks at ZT1 in dorsal striatum but at ZT13 in the SCN.
- Unilateral 6-OHDA lesions of the medial forebrain bundle blunt the dorsal striatum PER2 rhythm on the lesioned side, with significant reductions at ZT1 and ZT19, while SCN PER2 is unaffected.
- AMPT treatment reduced dorsal striatum dopamine content by 95% at ZT13 and 88% at ZT1, reduced PER2 at ZT1, and slightly increased PER2 at ZT13; SCN PER2 was unchanged.
- Chronic raclopride (D2 antagonist) reduced dorsal striatum PER2 at ZT1, whereas SCH 23390 (D1 antagonist) had no effect. Daily quinpirole (D2/3 agonist) at ZT1 restored and reversed the PER2 rhythm in 6-OHDA-lesioned striatum, increasing PER2 at ZT13; daily SKF 81297 (D1 agonist) and continuous quinpirole infusion had no effect.
Methods
- Male Wistar rats (n = 172 total) housed on a 12 h light/dark cycle; experiments used unilateral 6-OHDA medial forebrain bundle lesions, AMPT injections, osmotic minipumps for D1/D2 antagonists or agonists, and daily agonist injections.
- PER2 and PER1 immunoreactive nuclei were counted in dorsal striatum and SCN; DAT staining confirmed lesions; RT-PCR measured Per2 transcription; in vivo microdialysis measured extracellular dorsal striatum dopamine; wheel-running activity was monitored.
- Analyses used mixed-model or two-way ANOVA with ZT and treatment/lesion as factors, followed by Bonferroni-corrected post hoc tests or t tests; α = 0.05.
Limitations
- The paper states that the mechanisms whereby dopamine depletion and D2 receptor activation suppress and restore PER2 remain unresolved, and it leaves open a possible role for noradrenaline because AMPT also prevents noradrenaline synthesis.
- Evident from the text: the dopamine rhythm was measured in only three rats, and several experimental groups had small n values (e.g., 2–3 per ZT in some conditions), limiting precision.
- Evident from the text: the phase relationship between dopamine and PER2 is correlational, and the study does not identify the molecular pathway linking D2 receptor activation to Per2 transcription.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 38 cited sources checked · 0 supported · 0 flagged
- Findingown data
Depletion of striatal DA by 6-OHDA or AMPT or blockade of D2 DA receptors by raclopride blunts the rhythm of striatal PER2.
“depletion of striatal DA by 6-hydroxydopamine or ␣-methyl-para-tyrosine or blockade of D 2 DA receptors by raclopride blunts the rhythm of striatal PER2”
Quote in the paperSubstantial claim- Rests on an assumption: Raclopride acts selectively as a D2 dopamine receptor antagonist.
- Rests on an assumption: Unilateral 6-OHDA injection into the MFB selectively destroys dopaminergic inputs to the dorsal striatum without affecting other neurotransmitter systems.
- Rests on an assumption: AMPT selectively inhibits tyrosine hydroxylase and depletes dopamine without affecting other catecholamines.
- Findingown data
The peak of the daily rhythm of extracellular DA in the dorsal striatum precedes the peak of PER2 by approximately 6 hours.
“the peak of the daily rhythm of extracellular DA in the dorsal striatum precedes the peak of PER2 by ϳ6 h”
Quote in the paperSubstantial claim - Findingown data
None of the manipulations (6-OHDA, AMPT, raclopride, D2/D1 agonists) had any effect on the PER2 rhythm in the SCN.
“None of these manipulations had any effect on the PER2 rhythm in the SCN.”
Quote in the paperSubstantial claim - Findingown data
There is a direct relationship between extracellular DA levels and the rhythm of expression of PER2 in the dorsal striatum of the male Wistar rat.
“we demonstrate a direct relationship between extracellular DA levels and the rhythm of expression of the clock protein PERIOD2 (PER2) in the dorsal striatum of the male Wistar rat.”
Quote in the paperSubstantial claim - Findingown data
In the SCN, the rhythm of PER2 expression peaks in the evening, in antiphase to that in the dorsal striatum.
“In the SCN, the rhythm of PER2 expression peaks in the evening, in antiphase to that in the dorsal striatum (Figs. 1, 2b).”
Quote in the paperNot a substantial claim
- Findingown data
PER2 expression in the 6-OHDA-lesioned striatum was significantly reduced at ZT1 and ZT19.
“PER2 expression in the 6-OHDA-lesioned striatum was significantly reduced at ZT1 (t (5) ϭ 13.60; p Ͻ 0.01) and ZT19 (t (3) ϭ 7.41; p Ͻ 0.01).”
Quote in the paperSubstantial claim - Findingown data
A similar reduction in activity levels was observed in vehicle-treated rats.
“a similar reduction in activity levels was observed in vehicle-treated rats”
Quote in the paperSubstantial claim - Findingown data
The blunting of peak PER2 expression in the dorsal striatum after a unilateral 6-OHDA lesion does not recover with time, even when rats have access to running wheels in the intervening period.
“This finding indicates that the blunting of peak PER2 expression in the dorsal striatum after a unilateral 6-OHDA lesion does not recover with time, even when rats have access to running wheels in the intervening period.”
Quote in the paperSubstantial claim - Findingown data
PER2 expression in the SCN was not affected in either 6-OHDA or vehicle treatment group.
“PER2 expression in the SCN was not affected in either treatment group”
Quote in the paperSubstantial claim - Findingown data
In the SCN, the 6-OHDA injection had no effect on the normal rhythm of PER2-IR in either the lesioned or the intact hemispheres.
“In the SCN (Fig. 4d), the 6-OHDA injection had no effect on the normal rhythm of PER2-IR in either the lesioned or the intact hemispheres”
Quote in the paperSubstantial claim - Findingown data
Extracellular DA levels in the dorsal striatum fluctuate in a circadian rhythm, falling during the light phase and peaking in the middle of the dark phase.
“extracellular DA levels in the dorsal striatum (expressed as picograms of DA/microliter of dialysate) fluctuate in a circadian rhythm falling during the light phase and peaking in the middle of the dark phase.”
Quote in the paperSubstantial claim - Findingown data
PER2 expression at ZT1 was significantly reduced in the lesioned hemisphere compared with the intact hemisphere 28 d after the 6-OHDA injection.
“PER2 expression at ZT1 was significantly reduced in the lesioned hemisphere compared with the intact hemisphere 28 d after the 6-OHDA injection (data not shown)”
Quote in the paperSubstantial claim - Findingown data
There was no effect on PER2 in vehicle-injected rats in either hemisphere.
“there was no effect on PER2 in vehicle-injected rats in either hemisphere”
Quote in the paperSubstantial claim - Findingown data
The amount of nighttime activity in the 6-OHDA-lesioned rats is significantly reduced.
“the amount of nighttime activity in the 6-OHDA-lesioned rats is significantly reduced”
Quote in the paperNot a substantial claim - Findingown data
In 6-OHDA-treated rats, PER2 expression in the dorsal striatum was significantly reduced at ZT1 on the lesioned side.
“in 6-OHDA-treated rats, PER2 expression in the dorsal striatum was significantly reduced at ZT1 on the lesioned side”
Quote in the paperSubstantial claim - Findingown data
In 6-OHDA-lesioned rats, wheel-running activity across the 24 h period remains rhythmic.
“although wheel-running activity across the 24 h period remains rhythmic”
Quote in the paperSubstantial claim - Findingown data
The rhythm of extracellular DA levels in the dorsal striatum is significantly out of phase with the PER2 rhythm in the dorsal striatum.
“this rhythm of extracellular DA levels in the dorsal striatum, while resembling the PER2 rhythm in the SCN, is significantly out of phase with the PER2 rhythm in the dorsal striatum.”
Quote in the paperSubstantial claim - Findingown data
Quinpirole dramatically increased expression of PER2 at ZT13 in the lesioned dorsal striatum.
“dramatically increased expression of PER2 at ZT13”
Quote in the paperSubstantial claim - Findingown data
A unilateral 6-OHDA lesion had no effect on PER2 expression in M1 or DG in either hemisphere.
“a unilateral 6-OHDA lesion had no effect on PER2 expression in M1 (Fig. 9a) or DG (Fig. 9c) in either hemisphere.”
Quote in the paperSubstantial claim - Findingown data
PER2 expression in the dorsal striatum was significantly reduced at ZT1 by chronic infusion of the D2 DA antagonist raclopride.
“was significantly reduced at ZT1 by chronic infusion of the D 2 DA antagonist, raclopride”
Quote in the paperSubstantial claim - Findingown data
AMPT significantly reduced PER2 expression at ZT1 in the dorsal striatum compared with vehicle.
“AMPT significantly reduced PER2 expression at ZT1”
Quote in the paperSubstantial claim - Findingown data
No differences in PER2 expression between groups were found at ZT13 in the dorsal striatum.
“No differences in PER2 expression between groups were found at ZT13 in the dorsal striatum”
Quote in the paperNot a substantial claim - Findingown data
AMPT treatment produced an 88% reduction in DA content in the dorsal striatum at ZT1.
“an 88% reduction in DA content in AMPT-treated rats killed at ZT1”
Quote in the paperSubstantial claim - Findingown data
The 6-OHDA lesion did not affect PER1 in the SCN.
“the 6-OHDA lesion did not affect PER1 in the SCN”
Quote in the paperNot a substantial claim - Findingown data
In the intact hemisphere, Per2 transcription levels are greater at ZT19 than ZT7.
“In the intact hemisphere, Per2 transcription levels are greater at ZT19 than ZT7.”
Quote in the paperSubstantial claim - Findingown data
Systemic AMPT treatment dramatically decreased PER2 expression at ZT1 in both M1 and DG.
“systemic AMPT treatment dramatically decreased PER2 expression at ZT1 in both M1 (Fig. 9b) and DG (Fig. 9d).”
Quote in the paperSubstantial claim - Findingown data
In both M1 and DG, the normal daily fluctuation in PER2 expression peaks at ZT1 and falls at ZT13.
“In both M1 and DG, the normal daily fluctuation in PER2 expression peaks at ZT1 and falls at ZT13”
Quote in the paperSubstantial claim - Findingown data
Quinpirole injections had no effect on the normal daily variation in PER2 expression in the intact dorsal striatum.
“quinpirole injections had no effect on the normal daily variation in PER2 expression in the intact dorsal striatum”
Quote in the paperSubstantial claim - Findingown data
Quinpirole had no effect on PER2 expression at ZT1 in the lesioned dorsal striatum.
“quinpirole had no effect on PER2 expression at ZT1”
Quote in the paperNot a substantial claim - Findingown data
After the 6-OHDA lesion, the amplitude of the PER1 rhythm in the lesioned hemisphere was significantly blunted compared with the intact hemisphere.
“After the 6-OHDA lesion, the amplitude of this rhythm in the lesioned hemisphere was significantly blunted compared with the intact hemisphere”
Quote in the paperSubstantial claim - Findingown data
Per2 transcription at ZT19 was unaffected by a vehicle injection.
“but were unaffected by a vehicle injection”
Quote in the paperNot a substantial claim - Findingown data
AMPT slightly increased PER2 expression at ZT13 in the dorsal striatum compared with vehicle.
“slightly increased it at ZT13 compared with the vehicle group”
Quote in the paperNot a substantial claim - Findingown data
Levels of Per2 transcription at ZT19 were significantly reduced in the dorsal striatum ipsilateral to a 6-OHDA injection.
“levels of Per2 transcription at ZT19 were signifi-cantly reduced in the dorsal striatum ipsilateral to a 6-OHDA injection”
Quote in the paperSubstantial claim - Findingown data
AMPT treatment had no effect on PER2 expression in the SCN.
“AMPT treatment had no effect on PER2 expression in the SCN”
Quote in the paperSubstantial claim - Findingown data
PER1 was significantly reduced in the lesioned hemisphere at ZT1 and ZT19.
“PER1 was significantly reduced in the lesioned hemisphere at ZT1 ( p Ͻ 0.05) and ZT19 ( p Ͻ 0.05).”
Quote in the paperNot a substantial claim - Findingown data
PER2 expression in the dorsal striatum was unaffected by 5 d of chronic treatment with the D1 DA antagonist SCH 23390.
“PER2 expression was unaffected by 5 d of chronic treatment with the D 1 DA antagonist, SCH 23390”
Quote in the paperSubstantial claim - Findingown data
A unilateral 6-OHDA lesion blunted the daily variation of PER2 expression in the dorsal striatum on the lesioned side by strongly reducing the normal peak seen at ZT1.
“a unilateral 6-OHDA lesion blunted the daily variation of PER2 expression in the dorsal striatum on the lesioned side by strongly reducing the normal peak seen at ZT1”
Quote in the paperSubstantial claim - Findingown data
Neither SCH 23390 nor raclopride changed the normal daily variation in PER2 in the SCN.
“neither SCH 23390 nor raclopride changed the normal daily variation in PER2”
Quote in the paperSubstantial claim - Findingown data
AMPT treatment produced a 95% reduction in DA content in the dorsal striatum at ZT13.
“a 95% reduction in DA content in AMPTtreated rats killed at ZT13”
Quote in the paperSubstantial claim - Findingown data
Daily systemic injection of quinpirole at ZT1 restored and reversed the daily fluctuation of PER2 expression on the lesioned side.
“Daily systemic injection of quinpirole at ZT1 restored and reversed the daily fluctuation of PER2 expression on the lesioned side.”
Quote in the paperSubstantial claim - Findingown data
Daily injection of SKF 81297 at ZT1 had no effect on PER2 expression at ZT1 or ZT13 in either the lesioned or intact dorsal striatum.
“Daily injection of SKF 81297 at ZT1 (Fig. 11c) had no effect on PER2 expression at ZT1 or ZT13 in either the lesioned or intact dorsal striatum.”
Quote in the paperSubstantial claim - Findingown data
No changes in PER2 expression in the SCN were found after DA depletion or activation/blockade of DA receptors.
“Without exception, no changes in PER2 expression were found either after DA depletion or activation/blockade of DA receptors.”
- Also stated in: § Functional significance of PER2 regulation by DA · plain
“In the SCN, AMPT treatment had no effect on PER2 expression at either time point.”
- Also stated in: § Functional significance of PER2 regulation by DA · plain
“Neither raclopride nor SCH 23390 infusion affects PER2 in the SCN.”
Quote in the paperSubstantial claim - Also stated in: § Functional significance of PER2 regulation by DA · plain
- Findingown data
SKF 81297 increased activity during the day especially around the time of the injections.
“SKF 81297 increased activity during the day especially around the time of the injections”
Quote in the paperNot a substantial claim - Findingown data
Similar treatments with quinpirole or SKF 81297 had no effect on PER2 expression in the dorsal striatum or SCN of naive, intact rats.
“No effects of these drug treatments were found in either the dorsal striatum or SCN (data not shown).”
Quote in the paperSubstantial claim - Findingown data
The daily variation of PER2 expression in the SCN was unaffected by quinpirole or SKF 81297 injection.
“the daily variation of PER2 expression in the SCN was unaffected by quinpirole or SKF 81297 injection.”
Quote in the paperNot a substantial claim - Findingown data
6-OHDA had the expected effect on PER2 expression in the dorsal striatum at ZT1.
“6-OHDA had the expected effect on PER2 expression in the dorsal striatum at ZT1.”
Quote in the paperNot a substantial claim - Findingown data
Chronic infusion of a selective D2, but not D1, DA receptor antagonist attenuates the daily fluctuation in PER2 expression in the dorsal striatum.
“chronic infusion of a selective D 2 , but not D 1 , DA receptor antagonist attenuates the daily fluctuation in PER2 expression.”
Quote in the paperSubstantial claim - Findingown data
Treatment with AMPT suppressed PER2 expression within 24 h.
“treatment with AMPT, which blocks the synthesis of DA and other catecholamines acutely, suppressed PER2 expression within 24 h.”
Quote in the paperSubstantial claim - Findingown data
No effects were seen in the SCN with chronic delivery of quinpirole or SKF 81297.
“No effects were seen in the SCN (Fig. 12d-f ).”
Quote in the paperNot a substantial claim - Findingown data
Unilateral injection of 6-OHDA had no effect on the normal daily variation of PER2 expression in the SCN.
“unilateral injection of 6-OHDA had no effect on the normal daily variation of PER2 expression in the SCN”
Quote in the paperNot a substantial claim - Findingown data
Continuous infusion of the D2 DA agonist had no effect on PER2 in the lesioned striatum.
“Continuous infusion of the D 2 DA agonist had no effect”
Quote in the paperSubstantial claim - Findingown data
During the 10 d period of chronic infusion of quinpirole or SKF 81297, wheel-running activity remained rhythmic in all groups.
“during the 10 d period of chronic infusion of quinpirole or SKF 81297, wheel-running activity remained rhythmic in all groups”
Quote in the paperNot a substantial claim - Findingown data
Quinpirole strongly suppressed nocturnal activity.
“Quinpirole strongly suppressed nocturnal activity”
Quote in the paperNot a substantial claim - Findingown data
Similar injections of quinpirole in naive rats at the start of the dark phase strongly reduce the normal striatal peak of PER2 expression at ZT1.
“similar injections of quinpirole in naive rats at the start of the dark phase, when extracellular DA levels in the striatum are beginning to rise, strongly reduce the normal striatal peak of PER2 expression at ZT1”
Quote in the paperSubstantial claim - Findingown data
In the dorsal striatum, daytime PER2 expression was decreased on the 6-OHDA-lesioned side in vehicle-injected rats.
“In the dorsal striatum (a-c), daytime PER2 expression was decreased on the 6-OHDA-lesioned side in vehicle-injected rats (a)”
Quote in the paperSubstantial claim - Findingown data
Continuous infusion of quinpirole for 10 d has no effect on mean PER2 expression in either the 6-OHDA-lesioned or intact dorsal striatum.
“Continuous infusion of the D 2/3 agonist, quinpirole (0.5 mg ⅐ kg Ϫ1 ⅐ 24 h Ϫ1 ; n ϭ 2-3 per ZT), or the D 1 DA agonist, SKF 81297 (1 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 ; n ϭ 2-3 per ZT), for 10 d via osmotic minipump has no effect on mean (ϮSEM) PER2 expression in either the 6-OHDA-lesioned or intact dorsal striatum (b, c)”
Quote in the paperSubstantial claim - Findingown data
Daily injection of quinpirole selectively increased PER2 expression at ZT13 in the dorsal striatum of the 6-OHDA-lesioned hemisphere.
“Daily injection of quinpirole (b) selectively increased PER2 expression at ZT13 in the dorsal striatum of the 6-OHDA-lesioned hemisphere”
Quote in the paperSubstantial claim - Findingown data
Vehicle injection into the MFB does not disrupt the daily fluctuation in PER2 expression in the SCN.
“In the SCN, neither a unilateral 6-OHDA injection (b) nor a vehicle injection (e) into the MFB disrupts the daily fluctuation in PER2 expression.”
Quote in the paperSubstantial claim - Findingown data
Vehicle injection into the MFB has no effect on PER2 expression in the dorsal striatum.
“whereas a vehicle (VEH) injection into the MFB has no effect (d)”
Quote in the paperSubstantial claim - Findingown data
Infusion of the D1 DA antagonist SCH 23390 has no effect on daytime expression of PER2 in the dorsal striatum.
“whereas infusion of the D 1 DA antagonist, SCH 23390 (0.5 mg ⅐ kg Ϫ1 ⅐ 24 h Ϫ1 ), has no effect”
Quote in the paperSubstantial claim - Findingown data
PER2 is regulated by D2 DA receptor activity.
“and that PER2 is regulated by D 2 DA receptor activity”
Quote in the paperSubstantial claim - Findingown data
Treatment with AMPT strongly suppresses the normal peak of PER2 expression in primary motor cortex (M1).
“whereas treatment with AMPT strongly suppresses the normal peak of PER2 expression in each of these regions.”
Quote in the paperNot a substantial claim - Findingown data
Inhibition of tyrosine hydroxylase activity (AMPT) suppresses daytime PER2 expression in the dorsal striatum.
“Inhibition of tyrosine hydroxylase activity suppresses DA levels and daytime PER2 expression in the dorsal striatum.”
Quote in the paperSubstantial claim - Findingown data
Treatment with AMPT strongly suppresses the normal peak of PER2 expression in the dentate gyrus (DG).
“whereas treatment with AMPT strongly suppresses the normal peak of PER2 expression in each of these regions.”
Quote in the paperSubstantial claim - Findingown data
Loss of striatal DA can disrupt the rhythm of PER2 in the dorsal striatum.
“Our findings that loss of striatal DA can disrupt the rhythm of PER2, an essential component of the circadian clock”
Quote in the paperSubstantial claim - Findingown data
A unilateral 6-OHDA infusion into the MFB has no effect on PER2 in primary motor cortex (M1).
“A unilateral 6-OHDA infusion into the MFB has no effect on PER2 in primary motor cortex (M1) or in the dentate gyrus (DG)”
Quote in the paperSubstantial claim - Findingown data
In the dorsal striatum, AMPT treatment decreased PER2 expression at ZT1 compared with saline controls.
“In the dorsal striatum, AMPT treatment decreased daytime PER2 expression at ZT1 and increased PER2 at ZT13 compared with saline controls”
Quote in the paperSubstantial claim - Findingown data
The 24 h rhythm of PER2 immunoreactivity in the dorsal striatum is opposite in phase to the rhythm of PER2 expression in the SCN.
“the 24 h rhythm of PER2 immunoreactivity in the dorsal striatum (a) is opposite in phase to the rhythm of PER2 expression in the SCN (b)”
Quote in the paperNot a substantial claim - Findingown data
The normal 24 h rhythm in wheel running during the 10 d injection period was not disrupted by daily vehicle injection.
“The normal 24 h rhythm in wheel running during the 10 d injection period (g-i) was not disrupted by daily vehicle injection (g)”
Quote in the paperNot a substantial claim - Findingown data
Continuous infusion of the D2 DA receptor antagonist raclopride for 5 d reduces daytime expression of PER2 in the dorsal striatum.
“Continuous infusion of the D 2 DA receptor antagonist, raclopride (2 mg ⅐ kg Ϫ1 ⅐ 24 h Ϫ1 ), for 5 d via osmotic minipump reduces daytime expression of PER2 in the dorsal striatum”
Quote in the paperSubstantial claim - Findingown data
A unilateral 6-OHDA injection into the MFB causes loss of DA input to the striatum in the lesioned hemisphere.
“Lack of stain on the 6-OHDA side indicates a loss of DA input to the striatum in the lesioned hemisphere.”
Quote in the paperSubstantial claim - Findingown data
A unilateral 6-OHDA infusion into the MFB has no effect on PER2 in the dentate gyrus (DG).
“A unilateral 6-OHDA infusion into the MFB has no effect on PER2 in primary motor cortex (M1) or in the dentate gyrus (DG)”
Quote in the paperSubstantial claim - Findingown data
Daily injection of SKF 81297 had no effect on PER2 in the dorsal striatum of either the lesioned or intact hemisphere.
“whereas daily injection of SKF 81297 (c) had no effect on PER2 in either the lesioned or intact hemisphere”
Quote in the paperSubstantial claim - Findingown data
Dopaminergic manipulations did not affect the daily rhythm of locomotor activity.
“and is consistent with our finding that dopaminergic manipulations did not affect the daily rhythm of locomotor activity.”
Quote in the paperNot a substantial claim - Findingown data
Inhibition of tyrosine hydroxylase activity (AMPT) suppresses DA levels in the dorsal striatum.
“Inhibition of tyrosine hydroxylase activity suppresses DA levels and daytime PER2 expression in the dorsal striatum.”
- Also stated in: § Functional significance of PER2 regulation by DA · plain
“DA content in the dorsal striatum (expressed as picograms of DA/microgram of protein) in AMPTinjected rats (black bars) was significantly decreased at both ZT1 and ZT13 compared with saline-injected rats (white bars; n ϭ 2 per treatment group per ZT; *p Ͻ 0.05).”
Quote in the paperSubstantial claim - Also stated in: § Functional significance of PER2 regulation by DA · plain
- Findingown data
In the dorsal striatum, AMPT treatment increased PER2 expression at ZT13 compared with saline controls.
“In the dorsal striatum, AMPT treatment decreased daytime PER2 expression at ZT1 and increased PER2 at ZT13 compared with saline controls”
Quote in the paperSubstantial claim - Findingown data
A unilateral 6-OHDA lesion/injection into the MFB selectively reduces the normal morning peak of PER2 expression in the dorsal striatum ipsilateral to the lesion.
“A unilateral 6-OHDA injection into the MFB selectively reduces the normal morning peak of PER2 expression in the dorsal striatum ipsilateral to the lesion”
- Also stated in: § Functional significance of PER2 regulation by DA · plain
“Intra-MFB injection of 6-OHDA blunts the daytime increase in PER2 expression in the dorsal striatum”
Quote in the paperSubstantial claim - Also stated in: § Functional significance of PER2 regulation by DA · plain
- Findingown data
Quinpirole injection suppressed nighttime wheel running.
“Quinpirole injection (h) suppressed nighttime wheel running”
Quote in the paperSubstantial claim - Findingown data
A unilateral 6-OHDA lesion does not affect the PER1 rhythm in the SCN.
“but does not affect the PER1 rhythm in the SCN”
Quote in the paperSubstantial claim - Findingown data
Continuous infusion of SKF 81297 for 10 d has no effect on mean PER2 expression in either the 6-OHDA-lesioned or intact dorsal striatum.
“Continuous infusion of the D 2/3 agonist, quinpirole (0.5 mg ⅐ kg Ϫ1 ⅐ 24 h Ϫ1 ; n ϭ 2-3 per ZT), or the D 1 DA agonist, SKF 81297 (1 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 ; n ϭ 2-3 per ZT), for 10 d via osmotic minipump has no effect on mean (ϮSEM) PER2 expression in either the 6-OHDA-lesioned or intact dorsal striatum (b, c)”
Quote in the paperSubstantial claim - Findingown data
A unilateral 6-OHDA injection into the MFB does not affect the PER2 rhythm in the SCN.
“but does not affect the PER2 rhythm in the SCN”
Quote in the paperSubstantial claim - Findingown data
A unilateral 6-OHDA lesion selectively reduces Per2 transcription in the dorsal striatum ipsilateral to the lesion.
“A unilateral 6-OHDA lesion selectively reduces Per2 transcription in the dorsal striatum ipsilateral to the lesion.”
Quote in the paperSubstantial claim - Interpretationown data
The rhythm of expression of PER2 in the dorsal striatum depends on daily dopaminergic activation of D2 DA receptors.
“Our findings are consistent with the idea that the rhythm of expression of PER2 in the dorsal striatum depends on daily dopaminergic activation of D 2 DA receptors.”
- Also stated in: § Introduction · boosted
“Our results establish endogenous DA, acting via D 2 DA receptors, as a regulator of PER2 rhythms in the dorsal striatum.”
Quote in the paperSubstantial claim- Rests on an assumption: Raclopride acts selectively as a D2 dopamine receptor antagonist.
- Rests on an assumption: Quinpirole acts selectively as a D2/3 dopamine receptor agonist.
- Rests on an assumption: Unilateral 6-OHDA injection into the MFB selectively destroys dopaminergic inputs to the dorsal striatum without affecting other neurotransmitter systems.
- Rests on an assumption: AMPT selectively inhibits tyrosine hydroxylase and depletes dopamine without affecting other catecholamines.
- Also stated in: § Introduction · boosted
- Premisecitation
Manipulations of DA receptors can alter the expression of some clock genes outside the SCN.
“A role for dopamine (DA) in the regulation of clock genes in the mammalian brain is suggested by evidence that manipulations of DA receptors can alter the expression of some clock genes outside the suprachiasmatic nucleus (SCN), the master circadian clock.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Doi et al., 2006
Not checked in the free run.
- cites Besharse et al., 2004;Yujnovsky et al., 2006
Not checked in the free run.
- cites Imbesi et al., 2009;Sahar et al., 2010
Not checked in the free run.
- Study design and conductown data
Unilateral 6-OHDA injection into the MFB causes a dramatic loss of dopaminergic fibers in the dorsal striatum ipsilateral to the toxin injection.
“The extent of the lesion was confirmed postmortem with immunohistochemical staining for expression of the dopamine transporter (DAT).”
- Also stated in: § PER2 expression after unilateral 6-OHDA lesion · plain
“Immunohistochemical staining of DAT expression confirmed that the unilateral 6-OHDA injection caused a dramatic loss of dopaminergic fibers in the dorsal striatum ipsilateral to the toxin injection (Fig. 3).”
Quote in the paperSubstantial claim - Also stated in: § PER2 expression after unilateral 6-OHDA lesion · plain
- Interpretationown data
The changes in PER2 in the striatum can be unambiguously attributed to the elimination of the DA innervation.
“indicating that the changes in PER2 in the striatum can be unambiguously attributed to the elimination of the DA innervation.”
Quote in the paperSubstantial claim - Interpretationown data
AMPT treatment results in a profound depletion of DA in the dorsal striatum.
“indicating a profound depletion of DA in the dorsal striatum as a result of this treatment”
Quote in the paperSubstantial claim - Interpretationown data
Changes in PER2 expression appear to be related specifically to DA and not to a reduction in locomotor activity.
“Thus, changes in PER2 expression appear to be related specifically to DA and not to a reduction in locomotor activity.”
Quote in the paperSubstantial claim - Interpretationown data
The reduction in PER2 protein in the dorsal striatum after a 6-OHDA lesion is at least partly attributable to a reduction in gene expression.
“suggest that the reduction in PER2 protein in the dorsal striatum after a 6-OHDA lesion is at least partly attributable to a reduction in gene expression.”
Quote in the paperSubstantial claim - Interpretationreasoning
The 6-OHDA lesion did not damage NA fibers in addition to DA fibers.
“the lack of effect of the 6-OHDA lesion on PER2 in these regions indicates that the lesion did not damage NA fibers in addition to DA fibers.”
Quote in the paperSubstantial claim - Interpretationown data
Dopaminergic input to the dorsal striatum regulates the transcription of Per2.
“These findings indicate that dopaminergic input to the dorsal striatum regulates the transcription of Per2”
Quote in the paperSubstantial claim - Interpretationown data
Catecholamines regulate the daily fluctuation in PER2 expression in M1 and DG.
“Together, these results indicate that catecholamines regulate the daily fluctuation in PER2 expression in M1 and DG.”
Quote in the paperSubstantial claim - Interpretationown data
Depletion of normal DA levels in the dorsal striatum by lesioning or pharmacological means blunts the normal daily peak in PER2 expression in this region.
“indicate that depletion of normal DA levels in the dorsal striatum by lesioning or pharmacological means blunts the normal daily peak in PER2 expression in this region.”
Quote in the paperSubstantial claim - Premisecitation
Longer delivery of DA antagonists is less effective than shorter-term treatment in blocking DA receptors because of increasing sensitivity of DA receptors over time.
“longer delivery of DA antagonists is less effective than shorter-term treatment in blocking DA receptors because of increasing sensitivity of DA receptors over time”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Samaha et al., 2008
Not checked in the free run.
- Interpretationreasoning
The catecholaminergic regulation of PER2 in M1 and DG is primarily attributable to NA.
“suggests that the catecholaminergic regulation of PER2 in these regions is primarily attributable to NA.”
Quote in the paperSubstantial claim - Interpretationown data
Treatments that deplete striatal DA strongly blunt the rhythm of PER2.
“treatments that deplete striatal DA strongly blunt the rhythm of PER2”
Quote in the paperSubstantial claim - Premisecitation
The daily peak of extracellular DA in the dorsal striatum preceded that of PER2 by ~6 h.
“The daily peak of extracellular DA in the dorsal striatum preceded that of PER2 by ϳ6 h.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Paulson and Robinson, 1994
Not checked in the free run.
- cites Castan ˜eda et al., 2004
Not checked in the free run.
- cites Amir et al., 2006
Not checked in the free run.
- Interpretationcitation
The 6-OHDA-lesioned hemisphere would be highly sensitive to D2 DA receptor stimulation.
“the 6-OHDA-lesioned hemisphere would be highly sensitive to D 2 DA receptor stimulation.”
Quote in the paperSubstantial claim - Interpretationreasoning
The absence of an effect of quinpirole injections on the PER2 rhythm in the intact striatum and in the striatum of naive rats is likely attributable to the time of day when injections were given.
“The absence of an effect of quinpirole injections on the PER2 rhythm in the intact striatum and in the striatum of naive rats is likely attributable to the time of day when injections were given.”
Quote in the paperSubstantial claim - Interpretationreasoning
There is a link between the daily rise of endogenous DA, D2 DA receptor activation, and the subsequent peak in PER2 expression in the dorsal striatum.
“Together, these findings point to a link between the daily rise of endogenous DA, D 2 DA receptor activation, and the subsequent peak in PER2 expression in the dorsal striatum.”
Quote in the paperSubstantial claim - Premisecitation
The dose of quinpirole used reliably inhibits the activity of DA neurons in naive rats through activation of D2 DA autoreceptors on DA cell bodies.
“The dose of quinpirole used in the present experiments has been shown to reliably inhibit the activity of DA neurons in naive rats through activation of D 2 DA autoreceptors on DA cell bodies”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Lacey et al., 1987 source
Not checked in the free run.
- cites Jeziorski and White, 1989
Not checked in the free run.
- Interpretationown data
A normal fluctuation in extracellular DA is necessary for the transcription of Per2 in the dorsal striatum.
“Our RT-PCR results suggest that a normal fluctuation in extracellular DA is necessary for the transcription of Per2 in the dorsal striatum.”
Quote in the paperSubstantial claim - Interpretationown data
Normal rhythmic expression of PER2 in the striatum relies on DA availability.
“normal rhythmic expression of PER2 in the striatum relies on DA availability.”
Quote in the paperSubstantial claim - Interpretationreasoning
An additional reduction in dopaminergic cell activity at ZT1 would have little impact on the normal PER2 rhythm.
“an additional reduction in dopaminergic cell activity at this time of day would have little impact on the normal PER2 rhythm.”
Quote in the paperSubstantial claim - Interpretationown data
The rhythm of PER2 in the striatum relies on phasic activation of D2 DA receptors.
“the rhythm of PER2 in the striatum relies on phasic activation of D 2 DA receptors.”
Quote in the paperSubstantial claim - Premisecitation
The adult SCN is impervious to dopaminergic manipulations.
“This insensitivity of the SCN is consistent with previous reports that the adult SCN, unlike the fetal SCN (Weaver et al., 1992;Schurov et al., 2002), is impervious to dopaminergic manipulations (Duffield et al., 1998;Masubuchi et al., 2000)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Weaver et al., 1992
Not checked in the free run.
- cites Schurov et al., 2002
Not checked in the free run.
- cites Duffield et al., 1998
Not checked in the free run.
- Interpretationreasoning
D2 signaling modulates PER2 expression at the level of transcription.
“Together, these results support the idea that D 2 signaling modulates PER2 expression at the level of transcription.”
Quote in the paperSubstantial claim - Interpretationown data
Changes in locomotor activity brought about by DA depletion or D2 DA receptor stimulation cannot explain the changes in PER2 expression.
“changes in locomotor activity brought about by DA depletion or, indeed, by D 2 DA receptor stimulation cannot explain the changes in PER2 expression.”
Quote in the paperSubstantial claim - Interpretationown data
The rhythm of expression of PER2 in the striatum depends on daily dopaminergic activation of D2 DA receptors.
“the rhythm of expression of PER2 in the striatum depends on daily dopaminergic activation of D 2 DA receptors.”
Quote in the paperSubstantial claim
- May combine two claims. 31
- Classified as probably not a substantial claim. 13
May combine two claims.
Findingown dataTimed daily activation of D2 DA receptors, but not D1 DA receptors, restores and entrains the PER2 rhythm in the DA-depleted striatum.
“timed daily activation of D 2 DA receptors, but not D 1 DA receptors, restores and entrains the PER2 rhythm in the DA-depleted striatum”
Quote in the paperSubstantial claim- Rests on an assumption: Quinpirole acts selectively as a D2/3 dopamine receptor agonist.
May combine two claims.
Findingown dataThe rhythm of PER2 expression in the dorsal striatum peaks in the morning at ZT1 and reaches its trough in the evening at ZT13.
“the rhythm of PER2 expression in the dorsal striatum peaks in the morning, at the beginning of the light phase (ZT1), and reaches its trough in the evening, at the beginning of the dark phase (ZT13).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe 6-OHDA injection severely blunted the rhythm of PER2 expression in the lesioned hemisphere, but did not affect the normal PER2 rhythm on the intact side.
“the 6-OHDA injection severely blunted the rhythm of PER2 expression in the lesioned hemisphere, but did not affect the normal PER2 rhythm on the intact side”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWheel-running activity occurs primarily in the dark phase and is absent during the light phase.
“wheel-running activity occurs primarily in the dark phase and is absent during the light phase.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the SCN, the normal rhythm of PER1 expression is similar to the rhythm of PER2 and peaks near ZT13.
“In the SCN, the normal rhythm of PER1 expression is similar to the rhythm of PER2 and peaks near ZT13.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the dorsal striatum, the normal rhythm of PER1 expression approximates the rhythm of PER2 in this region and peaks near ZT1.
“the normal rhythm of PER1 expression approximates the rhythm of PER2 in this region and peaks near ZT1.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDaily quinpirole injections restored the daily variation of PER2 expression in the lesioned striatum while suppressing nighttime activity, but had no effect on PER2 expression in the intact hemisphere.
“daily quinpirole injections restored the daily variation of PER2 expression in the lesioned striatum while suppressing nighttime activity, but had no effect on PER2 expression in the intact hemisphere.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeither daily injections nor continuous infusions of a D1 DA agonist were effective.
“Neither daily injections nor continuous infusions of a D 1 DA agonist were effective.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChronic delivery of quinpirole or SKF 81297 at the doses used did not alter the effect of lesions on PER2 expression in the dorsal striatum nor did they alter PER2 expression in the intact hemisphere.
“chronic delivery of quinpirole (Fig. 12b) or SKF 81297 (Fig. 12c) at the doses used did not alter the effect of lesions on PER2 expression in the dorsal striatum nor did they alter PER2 expression in the intact hemisphere.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAMPT depletion of catecholamines strongly reduced PER2 expression in the dorsal striatum, as well as in M1 and DG.
“AMPT depletion of catecholamines strongly reduced PER2 expression in this region, as well as in M1 and DG, which receive NA inputs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDaily injections of a D2 DA receptor agonist restored and shifted the daily peak of PER2 in the lesioned striatum.
“Daily injections of a D 2 DA receptor agonist, given to induce a peak of activation of DA receptors at a time of day when DA levels are normally low, not only restored, but shifted the daily peak of PER2 in the lesioned striatum.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWhen striatal DA was depleted unilaterally using 6-OHDA, the peak expression of PER2 on the lesioned side was strongly suppressed and the daily rhythm of PER2 in this region was blunted both 2 and 4 weeks after surgery.
“When striatal DA was depleted unilaterally using 6-OHDA, the peak expression of PER2 on the lesioned side was strongly suppressed and the daily rhythm of PER2 in this region was blunted both 2 and 4 weeks after surgery.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUnilateral depletion of striatal DA did not disrupt the daily activity rhythm even though the level of nighttime activity was reduced.
“Unilateral depletion of striatal DA, which strongly blunted the rhythm of PER2 expression on the lesioned side, did not disrupt the daily activity rhythm even though the level of nighttime activity was reduced.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDaily fluctuations in wheel-running activity peak at night, preceding the peak of PER2 in the striatum.
“The daily fluctuations in extracellular striatal DA levels (c) and wheelrunning activity (d) peak at night, preceding the peak of PER2 in the striatum.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataExtracellular DA levels in the dorsal striatum are lowest during the middle of the light phase and highest in the middle of the dark phase.
“In vivo microdialysis sampling in the dorsal striatum shows that extracellular DA levels are lowest during the middle of the light phase and highest in the middle of the dark phase”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDaily fluctuations in extracellular striatal DA levels peak at night, preceding the peak of PER2 in the striatum.
“The daily fluctuations in extracellular striatal DA levels (c) and wheelrunning activity (d) peak at night, preceding the peak of PER2 in the striatum.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the SCN, PER2 expression is greatest at ZT13 (near the beginning of the dark phase) and lowest during the light phase.
“in the SCN, PER2-IR nuclei are most abundant around ZT13”
- Also stated in: § Functional significance of PER2 regulation by DA · plain
“In the SCN, PER2 expression is greatest at ZT13, near the beginning of the dark phase, and is lowest during the light phase.”
Quote in the paperSubstantial claim- Also stated in: § Functional significance of PER2 regulation by DA · plain
May combine two claims.
Findingown dataNeither quinpirole nor SKF 81297 treatment affected daily wheel-running activity.
“Neither treatment affected daily wheel-running activity”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWheel-running activity is greatest during the dark phase and virtually absent during the light phase.
“Wheel-running activity is also greatest during the dark phase and is virtually absent during the light phase”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the dorsal striatum, PER2 expression is greatest at ZT1 (near the beginning of the light phase) and lowest during the dark phase.
“In the dorsal striatum, PER2-IR nuclei are most abundant around ZT1”
- Also stated in: § Functional significance of PER2 regulation by DA · plain
“In the dorsal striatum, PER2 expression is greatest at ZT1, near the beginning of the light phase, and is lowest during the dark phase”
Quote in the paperSubstantial claim- Also stated in: § Functional significance of PER2 regulation by DA · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCircadian rhythms of physiology and behavior are generated by a core set of clock genes, which regulate their own expression in a 24 h transcriptional-translational feedback cycle.
“Circadian rhythms of physiology and behavior are generated by a core set of clock genes, which regulate their own expression in a 24 h transcriptional-translational feedback cycle (for review, see Reppert and Weaver, 2001;Ko and Takahashi, 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Reppert and Weaver, 2001
Not checked in the free run.
- cites Ko and Takahashi, 2006
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenThe role of endogenous DA in the regulation of clock gene expression is unknown.
“The role of endogenous DA in the regulation of clock gene expression is unknown.”
- Also stated in: § Introduction · hedged
“There is no direct evidence, however, that endogenous DA regulates rhythmic expression of clock genes.”
Quote in the paperSubstantial claim- Also stated in: § Introduction · hedged
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe specificity of the PER2 and PER1 primary antibodies was previously confirmed with blocking experiments.
“The specificity of the PER2 and PER1 primary antibodies was previously confirmed with blocking experiments, in which addition of the PER2 peptide or the PER1 peptide (1 g/ml in PBS) to the primary incubation solution prevented staining of PER2 or PER1 expression, respectively, in the tissue (Hastings et al., 1999;Field et al., 2000).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Hastings et al., 1999
Not checked in the free run.
- cites Field et al., 2000
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe rhythms of PER2 expression in the SCN, extracellular DA levels in the dorsal striatum, and wheel running are in phase with one another, but are in antiphase to the rhythm of PER2 expression in the dorsal striatum.
“Thus, the rhythms of PER2 expression in the SCN, extracellular DA levels in the dorsal striatum, and wheel running are in phase with one another, but are in antiphase to the rhythm of PER2 expression in the dorsal striatum.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataWe found no differences between the two PER2 primary antibodies in the pattern or amount of staining for PER2 in a number of different brain regions.
“We found no differences between these primary antibodies in the pattern or amount of staining for PER2 in a number of different brain regions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExtra-SCN rhythms can be influenced independently by a variety of other signals, including steroid hormones, stressors, and restricted feeding schedules.
“Although signals from the SCN are required to maintain and coordinate rhythmic gene expression in the brain and periphery, these extra-SCN rhythms can also be influenced independently by a variety of other signals, including steroid hormones, stressors, and restricted feeding schedules (Takahashi et al., 2001;Wakamatsu et al., 2001;Perrin et al., 2006;Segall et al., 2006;Angeles-Castellanos et al.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Takahashi et al., 2001
Not checked in the free run.
- cites Wakamatsu et al., 2001
Not checked in the free run.
- cites Perrin et al., 2006
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPer2 plays a critical role in the regulation of the 24 h rhythm by serving as the interface between the negative and positive limbs of the cycle.
“Among these genes, Period2 (Per2) plays a critical role in the regulation of this 24 h rhythm by serving as the interface between the negative and positive limbs of the cycle (Chen et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenRats were randomly assigned to an experimental condition.
“Rats were left in their home cages for at least 10 d to entrain to the LD cycle before the start of each experiment and were randomly assigned to an experimental condition.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe rhythms of PER2 expression were consistent across medial and lateral regions of the striatum, and the effects of each experimental manipulation on their expression did not vary within the striatum.
“We found that the rhythms of PER2 expression were consistent across these regions and that the effects of each experimental manipulation on their expression did not vary within the striatum.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn mammals, the master circadian clock resides in the SCN, and the phase of rhythmic clock gene expression in this region is entrained by environmental light.
“In mammals, the master circadian clock resides in the suprachiasmatic nucleus (SCN), and the phase of rhythmic clock gene expression in this region is entrained by environmental light (Lowrey and Takahashi, 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lowrey and Takahashi, 2000
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRhythmic clock gene expression is not limited to the SCN and has been characterized in several other regions of the brain and in peripheral tissues.
“Rhythmic clock gene expression is not limited to the SCN, however, and has been characterized in several other regions of the brain and in peripheral tissues (Abe et al., 2002;Shieh, 2003;Amir et al., 2004;Lamont et al., 2005;Guilding and Piggins, 2007).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Abe et al., 2002 source
Not checked in the free run.
- cites Shieh, 2003
Not checked in the free run.
- cites Amir et al., 2004
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataData were analyzed only from those rats with complete unilateral lesions, as confirmed by an absence of DAT staining in the dorsal striatum ipsilateral to the 6-OHDA injection.
“In the experiments involving unilateral injections of 6-OHDA toxin into the MFB, data were analyzed only from those rats with complete unilateral lesions, as confirmed by an absence of DAT staining in the dorsal striatum ipsilateral to the 6-OHDA injection.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationActivation of D2 receptors modulates the circadian effects of light on locomotor activity in mice and regulates expression of clock genes in the retina and striatum.
“In particular, activation of D 2 receptors has been demonstrated to modulate the circadian effects of light on locomotor activity in mice (Doi et al., 2006) and to regulate expression of clock genes in the retina (Besharse et al., 2004;Yujnovsky et al., 2006) and striatum (Imbesi et al., 2009;Sahar et al., 2010), a region important for motor control, learning, cognition, and reward.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Doi et al., 2006
Not checked in the free run.
- cites Besharse et al., 2004;Yujnovsky et al., 2006
Not checked in the free run.
- cites Imbesi et al., 2009;Sahar et al., 2010
Not checked in the free run.
May combine two claims.
Study design and conductcitationThe doses of SCH 23390 and raclopride were chosen to occupy ~80% of striatal D1 or D2 DA receptors and did not impede motor function.
“The doses of SCH 23390 and raclopride were chosen on the basis of previous studies indicating dose ranges that were effective in occupying ϳ80% of striatal D 1 or D 2 DA receptors and that did not impede motor function”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Creese and Chen, 1985
Not checked in the free run.
- cites Neisewander et al., 1998
Not checked in the free run.
- cites Wadenberg et al., 2001; Kapur et al., 2003
Not checked in the free run.
May combine two claims.
Interpretationown dataA unilateral lesion of dopaminergic projections and subsequent depletion of DA in the dorsal striatum significantly blunts the normal rhythm of PER2 expression in this region without affecting the rhythm in the SCN.
“The results of our 6-OHDA experiments indicate that a unilateral lesion of dopaminergic projections and subsequent depletion of DA in the dorsal striatum significantly blunts the normal rhythm of PER2 expression in this region without affecting the rhythm in the SCN.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationThe drug doses used were in the range shown previously to enhance expression of immediate-early genes, striatal peptides, and electrophysiological responses of striatal neurons in 6-OHDA-lesioned rats.
“Drug doses were in the range shown previously to enhance expression of immediate-early genes, striatal peptides, and electrophysiological responses of striatal neurons in 6OHDA-lesioned rats”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Gerfen et al., 1990, 1995
Not checked in the free run.
- cites Hu et al., 1992
Not checked in the free run.
- cites Zhang et al., 2007; Ballion et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChanges in the expression of peptides and receptors in striatal medium spiny neurons that develop after a unilateral 6-OHDA lesion can be reversed with intermittent or chronic DA receptor agonist treatment.
“changes in the expression of peptides and receptors in striatal medium spiny neurons that develop after a unilateral 6-OHDA lesion can be reversed with intermittent or chronic DA receptor agonist treatment”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gerfen et al., 1990
Not checked in the free run.
May combine two claims.
Interpretationown dataThe normal PER2 rhythm in the dorsal striatum depends on the availability of D2, but not D1, DA receptors.
“These results suggest that the normal PER2 rhythm in the dorsal striatum depends on the availability of D 2 , but not D 1 DA receptors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationExtracellular DA levels peak in the middle of the dark (active) phase and fall during the light (inactive) phase of the daily cycle.
“extracellular DA levels peak in the middle of the dark (active) phase and fall during the light (inactive) phase of the daily cycle”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Paulson and Robinson, 1994
Not checked in the free run.
- cites Castan ˜eda et al., 2004
Not checked in the free run.
May combine two claims.
PremisecitationPER2 expression peaks at the beginning of the light phase and reaches its trough near the beginning of the dark phase.
“PER2 expression peaks at the beginning of the light phase and reaches its trough near the beginning of the dark phase”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Amir et al., 2006
Not checked in the free run.
May combine two claims.
Interpretationown dataDaily stimulation of D2, but not D1, DA receptors restores and entrains the PER2 rhythm in the DA-depleted striatum.
“daily stimulation of D 2 , but not D 1 DA receptors, restores and entrains the PER2 rhythm in the DA-depleted striatum.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAfter a 6-OHDA lesion, the expression of D2 DA receptors on cell bodies is lost through destruction of DA fibers, whereas postsynaptic expression of D2 DA receptors in medium spiny neurons is upregulated.
“After a 6-OHDA lesion, however, the expression of D 2 DA receptors on cell bodies is lost through destruction of DA fibers, whereas postsynaptic expression of D 2 DA receptors in medium spiny neurons is upregulated”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gerfen et al., 1990
Not checked in the free run.
The paper relies on this without support.
Raclopride acts selectively as a D2 dopamine receptor antagonist.
“blockade of D 2 DA receptors by raclopride”
The paper relies on this without support.
Quinpirole acts selectively as a D2/3 dopamine receptor agonist.
“D 1 and D 2/3 DA receptor agonists, delivered either by timed daily injection”
The paper relies on this without support.
Unilateral 6-OHDA injection into the MFB selectively destroys dopaminergic inputs to the dorsal striatum without affecting other neurotransmitter systems.
“One hour before surgery, rats were injected intraperitoneally with desipramine (2.5 mg/kg) to protect noradrenergic fibers from the 6-OHDA toxin.”
The paper relies on this without support.
AMPT selectively inhibits tyrosine hydroxylase and depletes dopamine without affecting other catecholamines.
“injections of the tyrosine hydroxylase inhibitor ␣-methyl-para-tyrosine (AMPT)”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Striatal dopamine levels exhibit daily rhythms with nocturnal peaks in mice and rats.
“We have recently reported that striatal dopamine levels exhibit daily rhythms with nocturnal peaks in mice (Agostino et al., 2011a), as had been previously demonstrated in rats (Castaneda et al., 2004, Hood et al., 2010).”
From Circadian dysregulation in Parkinson's disease (2017) · cites this paper as Hood et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
PER1 sample sizes conflict with ANOVA degrees of freedom
MinorThe Figure 7 caption reports 5-6 rats at each of four time points, or at least 20 rats. The reported F(3,12) tests imply 16 rats across four time-point groups.
“main effect of ZT, F (3,12) ϭ 10.53, p Ͻ 0.01; main effect of lesion, F (1,12) ϭ 21.60, n.s.; ZT by lesion, F (3,12) ϭ 11.24, p Ͻ 0.05”
“SCN (b) in rats killed at ZT1, 7, 13, and 19, 2 weeks after 6-OHDA treatment (n ϭ 5-6 per ZT).”
AMPT striatal PER2 sample size conflicts with reported tests
MinorThe Figure 8 caption reports four rats per treatment group at each time point, implying 16 rats total and six degrees of freedom for each two-group t test. The reported ZT13 t test has five degrees of freedom, and the overall ANOVA has 11 residual degrees of freedom; both indicate one fewer rat.
“independent-samples t test, t (5) ϭ Ϫ3.22, p Ͻ 0.05”
“b, In the dorsal striatum, AMPT treatment decreased daytime PER2 expression at ZT1 and increased PER2 at ZT13 compared with saline controls (expressed as mean PER2-IR nuclei Ϯ SEM at each ZT; n ϭ 4 per treatment group per ZT; *p Ͻ 0.05).”
Cites
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967 · see citing works
Molecular components of the mammalian circadian clock
Ko, C. H., & Takahashi, J. S. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl207 · Cited by 1,657 · see citing works
Swanson, L. W., & Hartman, B. K. (1975) · The Journal of Comparative Neurology · doi:10.1002/cne.901630406 · Cited by 1,479 · see citing works
Molecular analysis of mammalian circadian rhythms
Reppert, S. M., & Weaver, D. R. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.647 · Cited by 1,444 · see citing works
Surmeier, D. J., Ding, J., Day, M., Wang, Z., & Shen, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.008 · Cited by 1,203 · see citing works
Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology
Watson, R. E., Wiegand, S. J., Clough, R. W., & Hoffman, G. E. (1986) · Peptides · doi:10.1016/0196-9781(86)90076-8 · Cited by 933 · see citing works
Mania-like behavior induced by disruption of <i>CLOCK</i>
Roybal, K., Theobold, D., Graham, A., DiNieri, J. A., Russo, S. J., Krishnan, V., Chakravarty, S., Peevey, J., Oehrlein, N., Birnbaum, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609625104 · Cited by 803 · see citing works
Beaulieu, J., Sotnikova, T. D., Yao, W., Kockeritz, L. K., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 792 · see citing works
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · cited 3× · see citing works
“Glutamate plays a key role in clock gene expression in the SCN (Reppert and Weaver, 2001) and after 6-OHDA lesions of DA inputs to the striatum there are changes in both glutamate release and responsiveness of D2 DA receptor-bearing striatopallidal neurons to glutamate (Day et al., 2006).”
BackgroundCircadian rhythms in isolated brain regions
Abe, M., Herzog, E. D., Yamazaki, S., Straume, M., Tei, H., Sakaki, Y., Menaker, M., & Block, G. D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00350.2002 · Cited by 681 · see citing works
Lacey, M. G., Mercuri, N. B., & North, R. A. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016787 · Cited by 614 · see citing works
The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption
Spanagel, R., Pendyala, G., Abarca, C., Zghoul, T., Sanchis-Segura, C., Magnone, M. C., Lascorz, J., Depner, M., Holzberg, D., Soyka, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1163 · Cited by 594 · see citing works
Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity
Bendová, Z., Cermakian, N., Reppert, S. M., & Sassone‐Corsi, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102075599 · Cited by 543 · see citing works
Eng, H., Lund, K., & Campenot, R. B. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00001.1999 · Cited by 507 · see citing works
Fallon, J. H., Koziell, D. A., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800308 · Cited by 497 · see citing works
Regulation of dopaminergic transmission and cocaine reward by the <i>Clock</i> gene
McClung, C. A., Sidiropoulou, K., Vitaterna, M., Takahashi, J. S., White, F. J., Cooper, D. C., & Nestler, E. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503584102 · Cited by 493 · see citing works
Kapur, S., VanderSpek, S. C., Brownlee, B. A., & Nóbrega, J. N. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046987 · Cited by 480 · see citing works
Cocaine sensitization and reward are under the influence of circadian genes and rhythm
Abarca, C., Albrecht, U., & Spanagel, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142039099 · Cited by 472 · see citing works
Regulation of Monoamine Oxidase A by Circadian-Clock Components Implies Clock Influence on Mood
Hampp, G., Ripperger, J. A., Houben, T., Schmutz, I., Blex, C., Perreau‐Lenz, S., Brunk, I., Spanagel, R., Ahnert‐Hilger, G., Meijer, J. H., et al. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.012 · Cited by 419 · see citing works
Tillerson, J. L., Caudle, W. M., Reverón, M. E., & Miller, G. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00096-4 · Cited by 399 · see citing works
A Role for Glycogen Synthase Kinase-3β in the Mammalian Circadian Clock
Iitaka, C., Miyazaki, K., Akaike, T., & Ishida, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503526200 · Cited by 373 · see citing works
Heterosynaptic Dopamine Neurotransmission Selects Sets of Corticostriatal Terminals
Bamford, N. S., Zhang, H., Schmitz, Y., Wu, N.-P., Cepeda, C., Levine, M. S., Schmauss, C., Zakharenko, S. S., Zablow, L., & Sulzer, D. (2004) · Neuron · doi:10.1016/s0896-6273(04)00265-x · Cited by 373 · see citing works
Guilding, C., & Piggins, H. D. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05581.x · Cited by 348 · see citing works
Field, M. D., Maywood, E. S., O'Brien, J. A., Weaver, D. R., Reppert, S. M., & Hastings, M. H. (2000) · Neuron · doi:10.1016/s0896-6273(00)80906-x · Cited by 343 · see citing works
Wakamatsu, H., Yoshinobu, Y., Aida, R., Moriya, T., Akiyama, M., & Shibata, S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01483.x · Cited by 308 · see citing works
Lowrey, P. L., & Takahashi, J. S. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.533 · Cited by 293 · see citing works
Regulation of BMAL1 Protein Stability and Circadian Function by GSK3β-Mediated Phosphorylation
Sahar, S., Zocchi, L., Kinoshita, C., Borrelli, E., & Sassone‐Corsi, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008561 · Cited by 291 · see citing works
Gerfen, C., Keefe, K., & Gauda, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-08167.1995 · Cited by 283 · see citing works
Castañeda, T. R., de Prado, B. M., Prieto, D., & Mora, F. (2004) · Journal of Pineal Research · doi:10.1046/j.1600-079x.2003.00114.x · Cited by 276 · see citing works
Wadenberg, M. L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00261-5 · Cited by 257 · see citing works
Lamont, E. W., Robinson, B., Stewart, J., & Amir, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500901102 · Cited by 256 · see citing works
Self-citationThe Catecholaminergic Innervation of the Rat Amygdala
Asan, E. (1998) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-642-72085-7 · Cited by 230 · see citing works
Chen, R., Schirmer, A. E., Lee, Y., Lee, H.-M., Kumar, V., Yoo, S. H., Takahashi, J. S., & Lee, C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.012 · Cited by 225 · see citing works
Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1
Yujnovsky, I., Hirayama, J., Doi, M., Borrelli, E., & Sassone‐Corsi, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510691103 · Cited by 199 · see citing works
Asan, E. (1998) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-642-72085-7_1 · Cited by 194 · see citing works
Cai, Y., Liu, S., Sothern, R. B., Xu, S., & Chan, P. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02848.x · Cited by 184 · see citing works
Masubuchi, S., Honma, S., Abe, H., Ishizaki, K., Namihira, M., Ikeda, M., & Honma, K. (2000) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2000.01313.x · Cited by 177 · see citing works
Amir, S., Lamont, E. W., Robinson, B., & Stewart, J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4488-03.2004 · Cited by 175 · see citing works
Self-citationHastings, M. H., Field, M. D., Maywood, E. S., Weaver, D. R., & Reppert, S. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-j0001.1999 · Cited by 166 · see citing works
Castellanos, A., Mendoza, J., & Escobar, C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.064 · Cited by 163 · see citing works
Uz, T., Ahmed, R., Akhisaroğlu, M., Kürtüncü, M., Imbesi, M., Arslan, A. D., & Manev, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.003 · Cited by 151 · see citing works
Dopamine receptor-mediated regulation of neuronal “clock” gene expression
Imbesi, M., Yildiz, S., Arslan, A. D., Sharma, R., Manev, H., & Uz, T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.044 · Cited by 141 · see citing works
Segall, L. A., Perrin, J. S., Walker, C. D., Stewart, J., & Amir, S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.037 · Cited by 141 · see citing works
Self-citationSelective D-1 dopamine receptor increase following chronic treatment with SCH 23390
Creese, I., & Chen, A. W. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90549-7 · Cited by 125 · see citing works
Iijima, M., Nikaido, T., Akiyama, M., Moriya, T., & Shibata, S. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02140.x · Cited by 122 · see citing works
Food‐entrainable circadian oscillators in the brain
Verwey, M., & Amir, S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06960.x · Cited by 113 · see citing works
Self-citationMontmayeur, J., & Borrelli, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3135 · Cited by 112 · see citing works
Distribution of the rhythm-related genes rPERIOD1, rPERIOD2, and rCLOCK, in the rat brain
Shieh, K.-R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00004-6 · Cited by 111 · see citing works
Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery
Samaha, A., Reckless, G. E., Seeman, P. M., Diwan, M., Nóbrega, J. N., & Kapur, S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.010 · Cited by 110 · see citing works
Nikaido, T., Akiyama, M., Moriya, T., & Shibata, S. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.894 · Cited by 102 · see citing works
Sa√±udo-Pe√±a, M. C., Force, M., Tsou, K., Miller, A. S., & Walker, J. M. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2 · Cited by 93 · see citing works
D1-dopamine receptors activate c-fos expression in the fetal suprachiasmatic nuclei.
Weaver, D. R., Rivkees, S. A., & Reppert, S. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9201 · Cited by 90 · see citing works
The expression of the clock protein PER2 in the limbic forebrain is modulated by the estrous cycle
Perrin, J. S., Segall, L. A., Harbour, V. L., Woodside, B., & Amir, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601310103 · Cited by 88 · see citing works
Self-citationLynch, W. J., Girgenti, M. J., Breslin, F. J., Newton, S. S., & Taylor, J. R. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.106 · Cited by 87 · see citing works
Paulson, P. E., & Robinson, T. E. (1994) · Behavioral Neuroscience · doi:10.1037//0735-7044.108.3.624 · Cited by 86 · see citing works
Bruguerolle, B., & Simon, N. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200207000-00002 · Cited by 83 · see citing works
Paulson, P. E., & Robinson, T. E. (1994) · Behavioral Neuroscience · doi:10.1037/0735-7044.108.3.624 · Cited by 83 · see citing works
Sorge, R. E., Rajabi, H., & Stewart, J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300712 · Cited by 82 · see citing works
Self-citationImpaired light masking in dopamine D2 receptor–null mice
Doi, M., Yujnovsky, I., Hirayama, J., Malerba, M., Tirotta, E., Sassone‐Corsi, P., & Borrelli, E. (2006) · Nature Neuroscience · doi:10.1038/nn1711 · Cited by 71 · see citing works
Regulation of photoreceptor Per1 and Per2 by light, dopamine and a circadian clock
Besharse, J. C., Zhuang, M., Freeman, K. C., & Fogerty, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03479.x · Cited by 50 · see citing works
Amir, S., & Stewart, J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.019 · Cited by 47 · see citing works
Self-citationAnstrom, K. K., Schallert, T. J., Woodlee, M. T., Shattuck, A., & Roberts, D. C. S. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.028 · Cited by 46 · see citing works
Zhang, H., Ma, L., Wang, F., Chen, J., & Zhen, X. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.004 · Cited by 44 · see citing works
Jeziorski, M. C., & White, F. J. (1989) · Synapse · doi:10.1002/syn.890040403 · Cited by 43 · see citing works
Pinealectomy does not affect diurnal PER2 expression in the rat limbic forebrain
Amir, S., Harbour, V. L., & Robinson, B. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.041 · Cited by 42 · see citing works
Self-citationD2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism
Ballion, B., Frenois, F., Zold, C. L., Chetrit, J., Murer, M. G., & Gonon, F. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.019 · Cited by 35 · see citing works
Verwey, M., Lam, G. Y. M., & Amir, S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06766.x · Cited by 29 · see citing works
Self-citationMoroz, I. A., Peciña, S., Schallert, T. J., & Stewart, J. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.012 · Cited by 29 · see citing works
Self-citationDuffield, Hastings, M. H., & Ebling, E. (1998) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1998.00274.x · Cited by 28 · see citing works
Hu, X., Brooderson, R. J., & White, F. J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90388-i · Cited by 26 · see citing works
Takahashi, S., Yokota, S.-I., Hara, R., Kobayashi, T., Akiyama, M., Moriya, T., & Shibata, S. (2001) · Endocrinology · doi:10.1210/endo.142.11.8487 · Cited by 18 · see citing works
Schurov, I., Hepworth, T. J., & Hastings, M. H. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01848.x · Cited by 17 · see citing works
Flagged first, then by citations
1 of the 73 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Circadian and sleep disorders in Parkinson's disease
Videnović, A., & Golombek, D. A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.018 · Cited by 247 · see citing works
Chronopharmacology: New Insights and Therapeutic Implications
Dallmann, R., Brown, S. A., & Gachon, F. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135923 · Cited by 244 · see citing works
Ishii, T., Warabi, E., & Mann, G. E. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.002 · Cited by 177 · see citing works
DNA methylation, a hand behind neurodegenerative diseases
Lu, H., Liu, X., Yu-Lin, D. E. N. G., & Qing, H. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00085 · Cited by 172 · see citing works
Dopamine: A Modulator of Circadian Rhythms in the Central Nervous System
Korshunov, K. S., Blakemore, L. J., & Trombley, P. Q. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00091 · Cited by 173 · see citing works
The brain’s reward system in health and disease
Lewis, R. G., Florio, E., Punzo, D., & Borrelli, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-81147-1_4 · Cited by 170 · see citing works
Circadian rhythms and mood regulation: insights from pre-clinical models
McClung, C. A. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.008 · Cited by 169 · see citing works
A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal
Blum, I. D., Zhu, L., Moquin, L., Kokoeva, M. V., Gratton, A., Giros, B., & Storch, K.-F. (2014) · eLife · doi:10.7554/elife.05105 · Cited by 168 · see citing works
The circadian clock: a framework linking metabolism, epigenetics and neuronal function
Masri, S., & Sassone‐Corsi, P. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3393 · Cited by 154 · see citing works
Neurodegeneration and the Circadian Clock
Hood, S., & Amir, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00170 · Cited by 150 · see citing works
Self-citationCao, R., Robinson, B., Xu, H., Gkogkas, C. G., Khoutorsky, A., Alain, T., Yanagiya, A., Nevarko, T., Liu, A. C., Amir, S., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.026 · Cited by 143 · see citing works
Self-citationThe adrenal peripheral clock: Glucocorticoid and the circadian timing system
Son, G. H., Chung, S., & Kim, K. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.07.003 · Cited by 136 · see citing works
Circadian insights into dopamine mechanisms
Mendoza, J., & Challet, É. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.081 · Cited by 124 · see citing works
Coque, L., Mukherjee, S., Cao, J.-L., Spencer, S., Marvin, M., Falcon, E., Sidor, M. M., Birnbaum, S. G., Graham, A., Neve, R. L., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.33 · Cited by 120 · see citing works
Circadian system — A novel diagnostic and therapeutic target in Parkinson's disease?
Videnović, A., & Willis, G. L. (2016) · Movement Disorders · doi:10.1002/mds.26509 · Cited by 115 · see citing works
Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson’s disease
Lauretti, E., Meco, A. D., Merali, S., & Praticò, D. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.47 · Cited by 109 · see citing works
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
Hunt, J., Coulson, E. J., Rajnarayanan, R. V., Oster, H., Videnović, A., & Rawashdeh, O. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00504-w · Cited by 113 · see citing works
Disrupted sleep and circadian rhythms in schizophrenia and their interaction with dopamine signaling
Ashton, A., & Jagannath, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00636 · Cited by 106 · see citing works
Regulation and function of extra‐SCN circadian oscillators in the brain
Begemann, K., Neumann, A., & Oster, H. (2020) · Acta Physiologica · doi:10.1111/apha.13446 · Cited by 102 · see citing works
Gallardo, C. M., Darvas, M., Oviatt, M., Chang, C. H., Michalik, M. J., Huddy, T. F., Meyer, E. E., Shuster, S. A., Aguayo, A., Hill, E. M., et al. (2014) · eLife · doi:10.7554/elife.03781 · Cited by 98 · see citing works
Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
Rasheed, M., Liang, J., Wang, C., Deng, Y., & Chen, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094956 · Cited by 94 · see citing works
Anderson, G., & Maes, M. H. J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8554-z · Cited by 90 · see citing works
Circadian rhythms in the blood–brain barrier: impact on neurological disorders and stress responses
Schurhoff, N. A., & Toborek, M. J. (2023) · Molecular Brain · doi:10.1186/s13041-023-00997-0 · Cited by 91 · see citing works
Circadian Clocks and Mood-Related Behaviors
Albrecht, U. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25950-0_9 · Cited by 86 · see citing works
A New Perspective for Parkinson’s Disease: Circadian Rhythm
Li, S., Wang, Y., Wang, F., Hu, L., & Liu, C. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0089-7 · Cited by 86 · see citing works
Minutes, days and years: molecular interactions among different scales of biological timing
Golombek, D. A., Bussi, I. L., & Agostino, P. V. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0465 · Cited by 80 · see citing works
Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease
Fifel, K., & Cooper, H. M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.024 · Cited by 80 · see citing works
Shumay, E., Fowler, J. S., Wang, G.-J., Logan, J., Alia-Klein, N., Goldstein, R. Z., Maloney, T., Wong, C., & Volkow, N. D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.11 · Cited by 79 · see citing works
Wang, Y., Lv, D.-J., Liu, W., Li, S., Chen, J., Shen, Y., Fen, W., Hu, L., & Liu, C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4854732 · Cited by 79 · see citing works
Suprachiasmatic Nucleus Neuropeptide Expression in Patients with Huntington's Disease
van Wamelen, D. J., Aziz, N. A., Anink, J. J., van Steenhoven, R., Angeloni, D., FRASCHINI, F., Jockers, R., Roos, R. A. C., & Swaab, D. F. (2012) · SLEEP · doi:10.5665/sleep.2314 · Cited by 77 · see citing works
Promoter methylation analysis of seven clock genes in Parkinson's disease
Lin, Q., Ding, H., Zheng, Z., Gu, Z., Ma, J., Chen, L., Chan, P., & Cai, Y. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.007 · Cited by 76 · see citing works
Gravotta, L., Gavrila, A. M., Hood, S., & Amir, S. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9520-8 · Cited by 74 · see citing works
Self-citationFifel, K., Vezoli, J., Dzahini, K., Claustrat, B., Leviel, V., Kennedy, H., Procyk, E., Dkhissi‐Benyahya, O., Gronfier, C., & Cooper, H. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086240 · Cited by 72 · see citing works
Willison, L. D., Kudo, T., Loh, D. H., Kuljis, D. A., & Colwell, C. S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.014 · Cited by 71 · see citing works
Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders
Barandas, R., Landgraf, D., McCarthy, M. J., & Welsh, D. K. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0637-2 · Cited by 68 · see citing works
Circadian neurons in the lateral habenula: Clocking motivated behaviors
Mendoza, J. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.013 · Cited by 69 · see citing works
Curtis, W. M., Seeds, W. A., Mattson, M. P., & Bradshaw, P. C. (2022) · Cells · doi:10.3390/cells11152416 · Cited by 70 · see citing works
Harbour, V. L., Weigl, Y., Robinson, B., & Amir, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076391 · Cited by 66 · see citing works
Self-citationTeijido, Ó., & Cacabelos, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103199 · Cited by 68 · see citing works
Food as circadian time cue for appetitive behavior
Mistlberger, R. E. (2020) · F1000Research · doi:10.12688/f1000research.20829.1 · Cited by 65 · see citing works
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
Perez‐Lloret, S., & Cardinali, D. P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.650597 · Cited by 64 · see citing works
Verwey, M., Dhir, S. K., & Amir, S. (2016) · F1000Research · doi:10.12688/f1000research.9180.1 · Cited by 62 · see citing works
Self-citationCircadian dysregulation in Parkinson's disease
Videnovic, A., & Golombek, D. (2017) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2016.11.001 · Cited by 63 · see citing works
Bright Light Therapy in Parkinson's Disease: An Overview of the Background and Evidence
Rutten, S., Vriend, C., van den Heuvel, O. A., Smit, J. H., Berendse, H. W., & van der Werf, Y. D. (2012) · Parkinson s Disease · doi:10.1155/2012/767105 · Cited by 63 · see citing works
French, I. T., & Muthusamy, K. A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00114 · Cited by 64 · see citing works
Involvement of dopamine signaling in the circadian modulation of interval timing
Bussi, I. L., Levín, G., Golombek, D. A., & Agostino, P. V. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12569 · Cited by 62 · see citing works
Neural Mechanisms of Circadian Regulation of Natural and Drug Reward
DePoy, L. M., McClung, C. A., & Logan, R. W. (2017) · Neural Plasticity · doi:10.1155/2017/5720842 · Cited by 61 · see citing works
Mattam, U., & Jagota, A. (2014) · Biogerontology · doi:10.1007/s10522-014-9541-0 · Cited by 62 · see citing works
Neurobiological Functions of the Period Circadian Clock 2 Gene, Per2
Kim, M., de la Peña, J. B., Cheong, J. H., & Kim, H. J. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.131 · Cited by 62 · see citing works
Weissová, K., Škrabalová, J., Skálová, K., Červená, K., Bendová, Z., Miletínová, E., Kopřivová, J., Šonka, K., Dudysová, D., Bartoš, A., et al. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2018.07.019 · Cited by 59 · see citing works
Genetic Factors Affecting Seasonality, Mood, and the Circadian Clock
Garbazza, C., & Benedetti, F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00481 · Cited by 55 · see citing works
Menon, J. M. L., Nolten, C., Achterberg, E. J. M., Joosten, R. N. J. M. A., Dematteis, M., Feenstra, M. G. P., Drinkenburg, W. H. (., & Leenaars, C. H. C. (2019) · Journal of Circadian Rhythms · doi:10.5334/jcr.174 · Cited by 57 · see citing works
Dopamine Is Involved in Food-Anticipatory Activity in Mice
Liu, Y., Liu, T.-Y., Qu, W., Hong, Z., Urade, Y., & Huang, Z. (2012) · Journal of Biological Rhythms · doi:10.1177/0748730412455913 · Cited by 57 · see citing works
Wang, Y., Du, W., Hu, X., Yu, X., Guo, C., Jin, X., & Wang, W. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.009 · Cited by 56 · see citing works
Diurnal and circadian regulation of reward-related neurophysiology and behavior
Webb, I. C., Lehman, M. N., & Coolen, L. M. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.02.034 · Cited by 56 · see citing works
Aging, circadian disruption and neurodegeneration: Interesting interplay
Verma, A. K., Singh, S., & Rizvi, S. I. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2022.112076 · Cited by 55 · see citing works
Circadian rhythms of hedonic drinking behavior in mice
Bainier, C., Mateo, M., Felder‐Schmittbuhl, M., & Mendoza, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.03.002 · Cited by 53 · see citing works
Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2020) · Cells · doi:10.3390/cells9020314 · Cited by 54 · see citing works
Circadian clock components in the rat neocortex: daily dynamics, localization and regulation
Rath, M. F., Rohde, K., Fahrenkrug, J., & Møller, M. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0415-4 · Cited by 51 · see citing works
Common variants in DRD2 are associated with sleep duration: the CARe consortium
Cade, B. E., Gottlieb, D. J., Lauderdale, D. S., Bennett, D. A., Buchman, A. S., Buxbaum, S. G., Jager, P. L. D., Evans, D. S., Fülöp, T., Gharib, S. A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv434 · Cited by 52 · see citing works
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8486-x · Cited by 52 · see citing works
Racing the clock: The role of circadian rhythmicity in addiction across the lifespan
Gulick, D., & Gamsby, J. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.003 · Cited by 50 · see citing works
Wang, F., Sun, L. Z., Zhang, X.-Z., Jia, J., Liu, Z., Huang, X., Yu, S., Zuo, L.-J., Cao, C.-J., Wang, X., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/692795 · Cited by 49 · see citing works
Schulte, E. C., & Winkelmann, J. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5933-0 · Cited by 49 · see citing works
Escobar, C., Salgado, R., Rodriguez, K., Blancas‐Velazquez, A. S., Castellanos, A., & Buijs, R. M. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.05.001 · Cited by 49 · see citing works
Food intake and addictive-like eating behaviors: Time to think about the circadian clock(s)
Mendoza, J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.003 · Cited by 46 · see citing works
Circadian regulation of appetite and time restricted feeding
Page, A. J., Christie, S., Symonds, E. L., & Li, H. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112873 · Cited by 43 · see citing works
Exosomes from Human Periapical Cyst-MSCs: Theranostic Application in Parkinson's Disease
Tatullo, M., Marrelli, B., Zullo, M. J., Codispoti, B., Paduano, F., Benincasa, C., Fortunato, F., Scacco, S., Zavan, B., & Cocco, T. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.41515 · Cited by 44 · see citing works
Clock genes, ADHD and aggression
Mogavero, F., Jager, A., & Glennon, J. C. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.002 · Cited by 44 · see citing works
The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms
Landgraf, D., Joiner, W. J., McCarthy, M. J., Kießling, S., Barandas, R., Young, J. W., Cermakian, N., & Welsh, D. K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.047 · Cited by 43 · see citing works
Dopaminergic Regulation of Circadian Food Anticipatory Activity Rhythms in the Rat
Smit, A. N., Patton, D. F., Michalik, M. J., Opiol, H., & Mistlberger, R. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082381 · Cited by 42 · see citing works
Diet-Induced Obesity and Circadian Disruption of Feeding Behavior
Blancas‐Velazquez, A. S., Mendoza, J., Garcia, A. N., & la Fleur, S. E. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00023 · Cited by 42 · see citing works
Hanna, M. E., Bednářová, A., Rakshit, K., Chaudhuri, A., O’Donnell, J. M., & Krishnan, N. (2015) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2015.01.001 · Cited by 42 · see citing works
Circadian rhythm alterations affecting the pathology of neurodegenerative diseases
Canever, J. B., Queiroz, L. Y., Soares, E. S., de Avelar, N. C. P., & Cimarosti, H. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15883 · Cited by 40 · see citing works
Ishii, T., Warabi, E., & Mann, G. E. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.026 · Cited by 40 · see citing works
Gonzalo-Gomez, A., Turiégano, E., León, Y., Molina, I., Torroja, L., & Canal, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036477 · Cited by 36 · see citing works
Li, H., Song, S., Wang, Y., Huang, C., Zhang, F., Liu, J., & Hong, J. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9968-1 · Cited by 36 · see citing works
Patton, D. F., Katsuyama, Â. M., Pavlovski, I., Michalik, M. J., Patterson, Z. R., Parfyonov, M., Smit, A. N., Marchant, E. G., Chung, J. J., Abizaid, A. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112451 · Cited by 35 · see citing works
Cocaine-mediated circadian reprogramming in the striatum through dopamine D2R and PPARγ activation
Brami‐Cherrier, K., Lewis, R. G., Cervantes, M., Liu, Y., Tognini, P., Baldi, P., Sassone‐Corsi, P., & Borrelli, E. (2020) · Nature Communications · doi:10.1038/s41467-020-18200-6 · Cited by 34 · see citing works
Circadian neurogenetics of mood disorders
Mendoza, J., & Vanotti, G. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03033-7 · Cited by 33 · see citing works
Circadian Clocks in the Regulation of Neurotransmitter Systems
Kiehn, J., Faltraco, F., Palm, D., Thome, J., & Oster, H. (2019) · Pharmacopsychiatry · doi:10.1055/a-1027-7055 · Cited by 28 · see citing works
Mysliveček, J. (2021) · Biomedicines · doi:10.3390/biomedicines9010025 · Cited by 32 · see citing works
Sasaki, T. (2017) · Nutrients · doi:10.3390/nu9101151 · Cited by 35 · see citing works
Dopamine D1 and D2 receptors are distinctly associated with rest-activity rhythms and drug reward
Zhang, R., Manza, P., Tomasi, D. G., Kim, S. W., Kojori, E. S., Demiral, Ş. B., Kroll, D. S., Feldman, D. E., McPherson, K. L., Biesecker, C. L., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149722 · Cited by 32 · see citing works
Bmal1 in the striatum influences alcohol intake in a sexually dimorphic manner
de Zavalía, N., Schoettner, K., Goldsmith, J. A., Solis, P., Ferraro, S., Parent, G., & Amir, S. (2021) · Communications Biology · doi:10.1038/s42003-021-02715-9 · Cited by 32 · see citing works
Self-citationLi, S., Wang, Y., Liu, W.-W., Lyu, D.-J., Wang, F., Mao, C., Yang, Y., Hu, L., & Liu, C. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.204920 · Cited by 32 · see citing works
Dorsal striatum dopamine oscillations: Setting the pace of food anticipatory activity
de Lartigue, G., & McDougle, M. J. (2018) · Acta Physiologica · doi:10.1111/apha.13152 · Cited by 32 · see citing works
Antibodies for assessing circadian clock proteins in the rodent suprachiasmatic nucleus
LeSauter, J., Lambert, C. M., Robotham, M. R., Model, Z., Silver, R., & Weaver, D. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035938 · Cited by 31 · see citing works
Itzhacki, J., Clesse, D., Goumon, Y., Someren, E. J. W. V., & Mendoza, J. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1655-8 · Cited by 31 · see citing works
Brain circadian clocks timing the 24h rhythms of behavior
Mendoza, J. (2025) · npj Biological Timing and Sleep · doi:10.1038/s44323-025-00030-8 · Cited by 24 · see citing works
Insights into the Role of the Habenular Circadian Clock in Addiction
Salaberry, N. L., & Mendoza, J. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00179 · Cited by 28 · see citing works
Altered resting-state connectivity within default mode network associated with late chronotype.
Horne, C., & Norbury, R. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.013 · Cited by 29 · see citing works
Dopamine Signaling in Circadian Photoentrainment: Consequences of Desynchrony.
Grippo, R. M., & Güler, A. D. (2019) · PubMed Central · Cited by 29 · see citing works
A mathematical model of circadian rhythms and dopamine
Kim, R., & Reed, M. C. (2021) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-021-00139-w · Cited by 29 · see citing works
Effects of a free-choice high-fat high-sugar diet on brain PER2 and BMAL1 protein expression in mice
Blancas‐Velazquez, A. S., la Fleur, S. E., & Mendoza, J. (2017) · Appetite · doi:10.1016/j.appet.2017.07.002 · Cited by 29 · see citing works
Kim, M., Custodio, R. J. P., Botanas, C. J., de la Peña, J. B., Sayson, L. V., Abiero, A., Ryoo, Z. Y., Cheong, J. H., & Kim, H. J. (2018) · Addiction Biology · doi:10.1111/adb.12663 · Cited by 29 · see citing works
Hood, S., Cassidy, P., Mathewson, S. A., Stewart, J., & Amir, S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.045 · Cited by 28 · see citing works
Self-citationFifel, K., Dkhissi‐Benyahya, O., & Cooper, H. M. (2013) · Chronobiology International · doi:10.3109/07420528.2012.762011 · Cited by 28 · see citing works
Effects of a new postnatal stress model on monoaminergic neurotransmitters in rat brains
Huppertz-Kessler, C. J., Poeschl, J., Hertel, R., Unsicker, K., & Schenkel, J. (2011) · Brain and Development · doi:10.1016/j.braindev.2011.07.008 · Cited by 28 · see citing works
Kerman, I. A., Clinton, S. M., Simpson, D. N., Bedrosian, T. A., Bernard, R., Akil, H., & Watson, S. J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.06.010 · Cited by 28 · see citing works
- Authors
- Hood, S., Cassidy, P., Cossette, M.-P., Weigl, Y., Verwey, M., Robinson, B., Stewart, J., & Amir, S.
- Affiliations
- Concordia University (CA)
- Corresponding author
- Amir, Shimon
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-10-20
- Volume
- 30
- Issue
- 42
- Pages
- 14046-14058
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6634752
- OpenAlex
- W1994354389
- Semantic Scholar
- 1e97e34ebe3618b16bc6ac1f8b26c1ab8625ec3b
- Cited by
- 246
- References
- 73
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 13 · 2023: 17 · 2022: 17 · 2021: 20 · 2020: 17 · 2019: 13 · 2018: 28 · 2017: 20 · 2016: 14 · 2015: 14 · 2014: 12 · 2013: 13 · 2012: 12
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Concordia University
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- dopamine, dopamine D2 receptor, Per2, clock genes, circadian rhythm, dorsal striatum, extracellular dopamine, 6-hydroxydopamine, alpha-methyl-p-tyrosine, raclopride, suprachiasmatic nucleus, Parkinson's disease, circadian entrainment
- MeSH terms
- Animals, Cell Count, Chromatography, High Pressure Liquid, Corpus Striatum, Dopamine, Gene Expression Regulation, Immunohistochemistry, Male, Medial Forebrain Bundle, Motor Activity, RNA, Suprachiasmatic Nucleus, Sympathectomy, Chemical, Sympatholytics, Tyrosine 3-Monooxygenase, Oxidopamine, Rats, Wistar, Receptors, Dopamine D2, Microdialysis, Reverse Transcriptase Polymerase Chain Reaction, Rats, Period Circadian Proteins, Dopamine D2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review